Sven berghe is the founder of PanTera. PanTera has raised $146M in total funding. Latest round: Series A. Based in Mol, Belgium.
Sven Van Den Berghe is the CEO of PanTera, a Belgian radioisotope producer specializing in scaling actinium-225 (Ac-225) production for cancer therapies. He led the company through its oversubscribed Series A round, securing €134 million, which was Belgium's largest life sciences deal.
Full founder directory · Investor directory · Company funding database · Fundraising library